Sleep apnea may increase atrial fibrillation risk

May 22, 2017, American Thoracic Society
A-fib risk and sleep apnea. Credit: ATS

Obstructive sleep apnea (OSA) may increase the risk of developing atrial fibrillation (AF), according to new research presented at the ATS 2017 International Conference.

OSA is characterized by repetitive episodes of shallow or paused breathing during sleep that lead to a drop in and disrupted sleep. AF is one of the most common cardiac arrhythmias characterized by a rapid and that can lead to stroke and related heart problems.

"There is strong biologic plausibility that may increase the risk of developing through a number of mechanisms," said lead author Tetyana Kendzerska, MD, PhD, assistant professor of medicine at the University of Ottawa in Canada. "There is emerging evidence from animals and smaller studies in humans that OSA may increase the chances of developing AF through oxidative stress, increased sympathetic activity, metabolic abnormalities, and cardiac stretch from intrathoracic pressure swings."

Researchers in Canada reviewed the records of 8,256 adults (average age 47) referred with suspected OSA, but free of any physician-diagnosed heart rate abnormalities, including AF at baseline. Participants were followed for up to 13 years. During that time, 173 developed AF resulting in hospitalization.

Before controlling for established risk factors for AF, the researchers found that measures of OSA severity such as the number of times an individual partially or completely stopped breathing per hour of sleep and sleep time spent with oxygen saturation lower than normal (< 90 percent) were significant predictors of AF.

Those who developed AF were more likely to be older, current or former smokers and have a high level of comorbidities. After adjusting for these and other known risk factors, the authors found that in sleep, but not the number of times an individual stops breathing, remained a significant predictor of AF hospitalizations. They also found the association between oxygen desaturation and AF hospitalization was stronger in women than men.

"Other studies have shown that women with sleep apnea are at greater risk of cardiovascular consequences, including mortality," said senior author Richard S. Leung, MD, PhD, assistant professor of medicine at the University of Toronto. "Greater endothelial dysfunction, higher propensity to develop pulmonary and systemic hypertension and impaired heart rate responses to autonomic challenges in women with OSA may explain these findings, but further studies are needed to confirm this finding and understand the potential mechanisms."

In their primary analysis, the researchers did not include hypertension. "Hypertension may be the causal pathway between OSA and AF, so including it might have diminished the association between OSA and AF," Dr. Kendzerska said. "However, in our secondary analysis, we did control for hypertension, and the association between oxygen desaturation and AF remained significant, suggesting that OSA can directly cause AF without the intermediate step of developing hypertension."

Study limitations include not having data on adherence to continuous positive air pressure (CPAP) treatment for OSA and whether a participant's was being treated or not. The authors are now analyzing data connecting OSA to emergency department visits for AF.

Explore further: Hard-to-treat hypertension may jeopardize sleep apnea patients' heart health

Related Stories

Hard-to-treat hypertension may jeopardize sleep apnea patients' heart health

July 18, 2016
In a study of patients with hypertension, those with resistant hypertension—meaning that their blood pressure remained elevated despite concurrent use of three antihypertensive agents of different classes—had a higher ...

Sleep apnea may raise heart risks in people with pacemakers

May 5, 2016
(HealthDay)—People with heart pacemakers and sleep apnea are at much greater risk for a dangerous heart rhythm disorder called atrial fibrillation, a new study suggests.

Predicting cardiovascular events in sleep apnea

February 4, 2014
Obstructive sleep apnea (OSA) generally is associated with increased risk for cardiovascular (CV) disease. OSA is usually measured using the apnea-hypopnea index (AHI), the number of times that breathing pauses or severely ...

Sleep-disordered breathing patients at greater risk for atrial fibrillation

December 9, 2015
Sleep-disordered breathing often predicts the development of atrial fibrillation (AF) in older men, according to U.S. researchers.

Oral devices reduce sleep apnea but may not affect heart disease risk factors

January 27, 2017
In patients with severe obstructive sleep apnea (OSA), oral appliances that treat the condition by moving the lower jaw forward appear to improve sleep but not reduce key risk factors for developing heart and other cardiovascular ...

Study finds that sleep apnea therapy has positive impact on hypertensive patients

October 28, 2016
A new study shows that positive airway pressure (PAP) therapy for sleep apnea may have a positive impact on sleep-related functional outcomes among patients who also suffer from hypertension. The findings suggest that untreated ...

Recommended for you

Synthetic cannabinoid reduces sleep apnea

November 29, 2017
A synthetic version of a molecule found in the cannabis plant was safe and effective in treating obstructive sleep apnea in the first large, multi-site study of a drug for the sleep disorder funded by the National Institutes ...

Sleeping through the snoring: Researchers identify neurons that rouse the brain to breathe

November 2, 2017
A common and potentially serious sleep disorder, obstructive sleep apnea affects at least one quarter of U.S. adults and is linked to increased risk of diabetes, obesity and cardiovascular disease. In a paper published today ...

Remede system approved for sleep apnea

October 9, 2017
(HealthDay)—The Remede sleep system, an implanted device that treats central sleep apnea by activating a nerve that sends signals to the diaphragm to stimulate breathing, has been approved by the U.S. Food and Drug Administration.

Inflammation may precede sleep apnea, could be treatment target

September 1, 2017
Inflammation is traditionally thought of as a symptom of sleep apnea, but it might actually precede the disorder, potentially opening the door for new ways to treat and predict sleep apnea, according to researchers.

More evidence: Untreated sleep apnea shown to raise metabolic and cardiovascular stress

August 31, 2017
Sleep apnea, left untreated for even a few days, can increase blood sugar and fat levels, stress hormones and blood pressure, according to a new study of sleeping subjects. A report of the study's findings, published in the ...

Sleep patterns contribute to racial differences in disease risk

August 18, 2017
Poor sleep patterns could explain, in part, the differences in the risk of cardiometabolic disease between African-Americans and European-Americans, according to a new study published in Proceedings of the National Academy ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.